INVESTIGADORES
SALOMON Horacio Eduardo
congresos y reuniones científicas
G. KOGAN; N. MORANDO; R. MARONE; L. SQUIQUERA; N. LAUFER; C. OCHOA; M.V. IANNANTUONO; M. VILA; H. SALOMON; M.A. PANDO
Data accessibility as a barrier towards achieving the UNAIDS 90-90-90 goals in the HIV cascade of care among men who have sex with men (MSM) in Buenos Aires, Argentina
IAS 2017 - 9th IAS Conference on HIV Science
Lugar: Paris; Año: 2017;
G. TURK; Y. GHIGLIONE; M. HORMANSTORFER; N. LAUFER; R. COLOCCINI; J. SALIDO; C. TRIFONE; M.J. RUIZ; J. FALIVENE; M.P. HOLGADO; M.P. CARUSO; M.I. FIGUEROA; H. SALOMON; L.D. GIAVEDONNI; M.A. PANDO; M.M. GHERARDI; D. RABINOVICH; P.A. PURY; O. SUED
Biomarkers of progression after HIV acute/early infection: nothing compares to CD4+ T-cell count?
IAS 2017 - 9th IAS Conference on HIV Science
Lugar: Paris; Año: 2017;
Y. GHIGLIONE; C. TRIFONE; J. SALIDO; A. SOLOMON; M.J. RUIZ; M.L. POLO; H. SALOMON; N. LAUFER; O. SUED; S.R. LEWIN; G. TURK
HIV reservoir size and composition, after antiretroviral treatment initiation, is related to HIV-specific CD8+ T-cell responses developed during primary HIV infection
IAS 2017 - 9th IAS Conference on HIV Science
Lugar: Paris; Año: 2017;
C. TRIFONE; J. SALIDO; M.J. RUIZ; L. LENG; R. BUCALA; H. SALOMON; F. QUIROGA; Y. GHIGLIONE; G. TURK
Enhancement of HIV-1 spreading and persistence by MIF/CD74 interaction in primary monocyte-derived macrophages (MDM) and CD4+ T-lymphocytes (CD4TL) in vitro
IAS 2017 - 9th IAS Conference on HIV Science
Lugar: Paris; Año: 2017;
Y.A. GHIGLIONE; M.J. RUIZ; J. SALIDO; C. TRIFONE; Y. MARTIN; P. PATTERSON; H. PEREZ; H. SALOMON; G. TURK; N. LAUFER
Modification of the HIV-specific CD8+ T cell responses in an elite controller after Chikungunya virus infection
21st International AIDS Conference (AIDS 2016)
Lugar: Durban; Año: 2016;
E. BISSIO; M.G. BARBAS; M.B. BOUZAS; H. SALOMON; A. CUDOLA; L. ESPÍNOLA; L. MAMMANA; S. KADEMIAN; S. FERNANDEZ GIULIANO; M.L. SUAREZ ORNANI; G. RAVASI; M. VILA; C. FALISTOCCO
Results of surveillance of HIV resistance in people starting antiretroviral treatment in Argentina performed according to WHO strategy
21st International AIDS Conference (AIDS 2016)
Lugar: Durban; Año: 2016;
G. DAMILANO; G. TURK; O. SUED; E. SOCIAS; M.J. RUIZ; F. GUZMAN; H. SALOMON; D. DILERNIA
Comparison of HIV epitopes availability between acute and chronic infection
21st International AIDS Conference (AIDS 2016)
Lugar: Durban; Año: 2016;
GUADALUPE SUAREZ; MATIAS ANGERAMI; MARIA VECCHIONE; HORACIO SALOMON; MARIA QUIROGA; OMAR SUED
CD8 T-Cell Terminal Differentiation and Its Regulation by DHEA in HIV-TB Coinfection
CROI 2015
Lugar: Seattle, Washington; Año: 2015;
A. DURAN; D. ROSSI; R. MARONE; G. ORELLANO; M. ROMERO; C. PETRACCA; E. BENEDETTI; M.M. AVILA; H. SALOMON ; M.A. PANDO
High acceptability of rapid HIV test in Argentina: experience during a seroprevalence study in vulnerable groups
IAS 2015 ? 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention ? 19 - 22 July 2015 ? Vancouver, Canada
Lugar: Vancouver; Año: 2015;
JULIANA FALIVENE ; YANINA A. GHIGLIONE; NATALIA L. LAUFER; MARÍA E. SOCÍAS; MARÍA J. RUIZ; PEDRO CAHN; OMAR SUED; HORACIO SALOMÓN; GABRIELA TURK; MARÍA M. GHERARDI
Th17 and Tregs at Early HIV Infection Influence Disease Progression and HIV Specific CD8+ Responses
CROI 2014
Lugar: Boston; Año: 2014;
YANINA GHIGLIONE; JULIANA FALIVENE; MARIA JULIA RUIZ; NATALIA LAUFER; MARIA EUGENIA SOCIAS; PEDRO CAHN; OMAR SUED; HORACIO SALOMON; MARIA MAGDALENA GHERARDI; GABRIELA TURK
Distribution of Bulk and HIV-specific CD81 T Cell Memory Phenotypes during Acute/Early HIV Infection Is Related to Reduced Antiviral Activity
HIV R4P. Research for prevention
Lugar: Ciudad del Cabo; Año: 2014;
MARIA JULIA RUIZ; YANINA GHIGLIONE; JULIANA FALIVENE; MARIA EUGENIA SOCIAS; NATALIA LAUFER; PEDRO CAHN; OMAR SUED; MARIA MAGDALENA GHERARDI; HORACIO SALOMON; ANA MARIA RODRIGUEZ; GABRIELA TURK
HIV-1 Env-specific IgA/IgG Ratio Is Related to Antibody Dependent Cellular Cytotoxicity (ADCC) Responses Observed during Acute/Early HIV Infection
HIV R4P. Research for prevention
Lugar: Ciudad del Cabo; Año: 2014;
D.C. MÓNACO ; M. QUIPILDOR; A DI PAOLO; R. COLOCCINI; G. THEILER; M. PANDO; L. FAINBOIM; E. HUNTER; H. SALOMON; D. DILERNIA
HLA-Associated Variation in HIV Viral Load in a South American Native Community with Limited HLA Diversity
AIDS Vaccine 2013
Lugar: Barcelona; Año: 2013;
D. DILERNIA; D. MONACO; M. QUIPILDOR; A. DI PAOLO; L. YUE; H. SALOMON; E. HUNTER
Evidence of less pathogenic HIV infection associated with higher adaptation to HLA-I mediated immune response: Insights from the study of the HIV-positive native community from Oran
AIDS Vaccine 2013
Lugar: Barcelona; Año: 2013;
R.S. COLOCCINI; Y. GHIGLIONE; G. TURK; N. LAUFER; M.E. SOCÍAS; O. SUED; P. CAHN; H. SALOMÓN; A. MANGANO; M.A. PANDO
Host genetic factors associated with symptomatic primary acute HIV infection and disease progression among Argentinean seroconverters
7TH IAS Conference on HIV Pathogenesis, Treatment and Prevention
Lugar: Kuala Lumpur ; Año: 2013;
G. DAMILANO; E. SOCIAS; C. MAGNERES; G. TURK; O. SUED; M. RUIZ; M. GOMEZ CARRILLO; H. SALOMON; D. DILERNIA
Rapid Detection of Early HIV-1 infections by direct sequencing of an hypervariable segment of the viral env gene.
AIDS Vaccine 2013
Lugar: Barcelona; Año: 2013;
C DE CANDIA; GABRIEL DUETTE; C ESPADA; H SALOMON; M CAROBENE
HIV-1 BF Intersubtype Recombinant Vpu Second Alpha Helix Plays an Important Role in the Viral Release and BST-2 Degradation
CROI 2013
Lugar: Atlanta; Año: 2013;
G. DAMILANO; E. SOCIAS; C. MAGNERES; G. TURK; M. GOMEZ- CARRILLO; H. SALOMON; D. DILERNIA
Low Selection Rate of HLA-Anchor Escape Mutations in HIV After Transmission of Subtype B and Recombinants BF Strains Patients from Argentina
AIDS Vaccine 2012
Lugar: Boston; Año: 2012;
DA DILERNIA; D MONACO; RS COLOCCINI; M PANDO; M QUIPILDOR; A DI PAOLO; E HUNTER; H SALOMON
Sequence based typing of HLA-A and B exons-2 and -3 in a HIV-positive native community with limited HLA diversity from the north of Argentina
AIDS Vaccine 2012
Lugar: Boston; Año: 2012;
D MONACO; D DILERNIA; L YUE; M QUIPILDOR; A DI PAOLO; E HUNTER; H SALOMON
First report on HIV molecular epidemiology in a native community from Argentina reveals transmission clades in the context of a unique HLA background
AIDS Vaccine 2012
Lugar: Boston; Año: 2012;
G TURK; N LAUFER; AM RODRIGUEZ; Y GHIGLIONE; J FALIVENE; MJ RUIZ; O SUED; L GIAVEDONI; P CAHN; H SALOMÓN; MM GHERARDI
Plasma Cytokine Levels and HIV-Specific
AIDS Vaccine 2012
Lugar: Boston; Año: 2012;
M.A. PANDO; R.S. COLOCCINI; N. SCHVACHSA; M. PIPPO; L. ALFIE; R. MARONE; M. GOMEZ CARRILLO; M.M. AVILA; H. SALOMON
Improved strategies for HIV diagnosis among men who have sex with men (MSM): a high prevalence and incidence population from Buenos Aires, Argentina (ORAL PRESENTATION)
XIX International AIDS Conference - AIDS 2012
Lugar: Washington DC; Año: 2012;
CRISTIAN DE CANDIA; Y GHIGLIONE; G DUETTE; G TURK; H SALOMÓN; M CAROBENE
HIV-1 Inter-subtype Recombinant Vpu Protein Shows an Improved Capacity to Down-modulate MHC-II Cell Surface Expression
18th Conference on Retroviruses and Opportunistic Infections
Lugar: Boston; Año: 2011;
YANINA GHIGLIONE; AM RODRIGUEZ; C DE CANDIA; L LENG; R BUCALA; M SCHINDLER; M CAROBENE; P BENAROCH; H SALOMÓN; G TURK
HIV-mediated Up-regulation of Invariant Chain (CD74/MIF Receptor) Contributes to Generalized Immune Activation
18th Conference on Retroviruses and Opportunistic Infections
Lugar: Boston; Año: 2011;
NATALIA LAUFER; L ABUSAMRA; A GUN; A KROLEWIECKI; H PÉREZ; H SALOMÓN; J QUARLERI; P CAHN
No Reduction of HCV Viral Load in HIV Patients Co-infected with HCV Genotype 1 during a 30- Day Course of NTZ Monotherapy
18th Conference on Retroviruses and Opportunistic Infections
Lugar: Boston; Año: 2011;
G. TURK; Y. GHIGLIONE; M.E. SOCIAS; A.M. RODRIGUEZ; J. FAVILENE; M.J. RUIZ; O. SUED; D. PRYLUKA; N. LAUFER; P. CAHN; M.M. GHERARDI; H. SALOMON
Frequency of CD4+ and CD8+ IL17-Secreting T Cells During Acute/Early HIV Infection and in Chronic Aviremic HIV Controllers
AIDS Vaccine 2011
Lugar: Bangkok; Año: 2011;
G. TURK; Y. GHIGLIONE; M.E. SOCÍAS; A.M. RODRIGUEZ; J. FAVILENE; M.J. RUIZ; O. SUED; D. PRYLUKA4; N. LAUFER; P. CAHN; H. SALOMON; M.M. GHERARDI
Differences in Magnitude, Breadth and Targets of HIV-Specific Response in Progressive Versus Non- Progressive Acute/Early HIV Infection
AIDS Vaccine 2011
Lugar: Bangkok; Año: 2011;
M. PANDO; M. WEISSENBACHER; R. MARONE; S.M. MONTANO; A. CARBALLO-DIEGUEZ4; H. SALOMÓN; M.M. AVILA
Men Who Have Sex with Men (MSM) from Buenos Aires, Argentina: A Suitable Group for HIV Clinical Trials
AIDS Vaccine 2011
Lugar: Bangkok; Año: 2011;
D. MONACO; D. DILERNIA; A. KROLEWIECKY; M. QUIPILDOR; A. DI PAOLO; G. THEILER; L. FAINBOIM; P. CAHN; H. SALOMÓN
High prevalence of CTL escape mutations on HIV strains circulating in a native population with limited HLA diversity
AIDS VACCINE 2010
Lugar: Atlanta; Año: 2010;
D.A. DILERNIA; D.C. MONACO; L.R. JONES; G.D. DAMILANO; S. RODRIGUEZ; H. SALOMÓN
The impact of HAART initiation on the selection and persistence of HIV-1 CTL-escape mutations
AIDS VACCINE 2010
Lugar: Atlanta; Año: 2010;
LUCILA CASSINO; N LAUFER; H SALOMÓN; J QUARLERI
Analysis of HBV Precore/core Promoter Variations in Mono-infected and HIV-co-infected Patients in a 3-Year Follow-up Study
16th Conference on Retroviruses and Opportunistic Infections
Lugar: Montreal; Año: 2009;
Y GHIGLIONE; P BENAROCH; H SALOMON; GABRIELA TURK
Invariant Chain Up-regulation in HIV-1-infected Monocyte-derived Macrophages Positively Correlates with Immune Activation in Seropositive Patients
16th Conference on Retrovirus and Opportunistic Infections
Lugar: Montreal; Año: 2009;
AE RUBIO; MA PANDO; DA DILERNIA; J TRINCHERO; NI ROVNER ; H SALOMON
Primary resistance in newly diagnosed HIV-1-infected drug-naïve individuals from Buenos Aires, Argentina: a two-period comparison
XVIII International HIV DRUG RESISTANCE WORKSHOP - Basic clinical and principal implications
Lugar: Fort Myers, Florida ; Año: 2009;
M VIGNOLES; G BARBONI; MR AGOSTI; M GARCÍA; S GONZÁLEZ-AYALA; H SALOMÓN
Evaluation of minority populations of HIV-1 with K103N and M184V resistance mutations among HIV-1-infected children in Buenos Aires, Argentina
XVIII International HIV DRUG RESISTANCE WORKSHOP - Basic clinical and principal implications
Lugar: Fort Myers, Florida ; Año: 2009;
M VIGNOLES; G BARBONI; MR AGOSTI; M GARCÍA; S GONZÁLEZ-AYALA ; H SALOMÓN
High frequency of primary mutations associated with antirretroviral drug resistance in reclently diagnosed HIV-infection children in Buenos Aires, Argentina
XVIII International HIV DRUG RESISTANCE WORKSHOP - Basic clinical and principal implications
Lugar: Fort Myers, Florida; Año: 2009;
C.A. DE CANDIA; TURK G; SARACCO M; SALOMÓN H; CAROBENE M
HIV-1 BF intersubtype recombinant Vpu protein increases viral particle
5TH IAS Conference on HIV Pathogenesis , Treatment and Prevention
Lugar: Ciudad del Cabo; Año: 2009;
D. DILERNIA; L.R. JONES; M. GOMEZ-CARRILLO; H. SALOMON
Estimation of the year of introduction of subtype-F HIV in America that
5TH IAS Conference on HIV Pathogenesis , Treatment and Prevention
Lugar: Ciudad del Cabo; Año: 2009;
M.A. PANDO; M. GÓMEZ-CARRILLO; M. VILA; D. ROSSI; G. RALÓN; M. VIGNOLES; J. TRINCHERO; A.E. RUBIO; R.MARONE; E. REYNAGA; J. SOSA; O. TORRES; M. MAESTRI; M.M. AVILA; H. SALOMÓN
HIV incidence and molecular characterization of new diagnoses in Argentina - a Global Fund project
5TH IAS Conference on HIV Pathogenesis , Treatment and Prevention
Lugar: Ciudad del Cabo; Año: 2009;
N. LAUFER; M. CAROBENE; G. TURK; O. SUED; Y. GHIGLIONE; A. KROLEWIECKI; C. CESAR; M. SARACCO; P. CAHN; H. SALOMÓN
Immune activation profile comparison between elite controllers and treated HIV-1(+) patients with undectable plasma viral load and low CD4 count recovery
5TH IAS Conference on HIV Pathogenesis , Treatment and Prevention
Lugar: Ciudad del Cabo; Año: 2009;
M.I. FIGUEROA; M. CAROBENE; A. RUBIO; F. MORETTI; R. TEJEIRO; P. CAHN; H. SALOMÓN
Long-term resistance monitoring in HAART experienced patients in Argentina
International AIDS Society (IAS) in partnership with South African registered not for profit organization Dira Sengwe
Lugar: Ciudad del Cabo; Año: 2009;
GABRIELA TURK,; P BENAROCH; H SALOMÓN
Nef proteins derived from HIV-1 subtypes C and F fail to up-regulate invarian chain cell surface expression.
CROI 2008 ? 15th Conference on Retroviruses and Opportunistic Infections.
Lugar: Boston MA, USA; Año: 2008;
M. VIGNOLES; G. BARBONI; M.R. AGOSTI; M. GARCÍA; I. FERRARI,; E. MAHLER; S. BRANDARIZ; S. GONZÁLEZ AYALA,; H. SALOMÓN
High frequency of antiretroviral drug resistance and low percentage of drug detection in plasma in HIV-infected children with virological failure
AIDS 2008 - XVII International AIDS Conference
Lugar: Mexico City; Año: 2008;
D.A. DILERNIA; C. CESAR; A. KROLEWIECKI; O. SUED; R. MARONE; N. LAUFER; M. GOMEZ-CARRILLO,; P. CAHN; H. SALOMÓN
Timely diagnosis of HIV infection reduces mortality in patients on HAART in Argentina. A
XVII International AIDS Conference.
Lugar: Mexico City; Año: 2008;
J.S. TRINCHERO HERNÁNDEZ; G TURK; A. PONCE; O.L. CÓRDOBA; M.L. FLORES; C.A. STORTZ; H. SALOMON
Antiretroviral activity of novel products extracted from brown seaweeds
AIDS 2008 - XVII International AIDS Conference
Lugar: Mexico City; Año: 2008;
G. TURK; M.M. GHERARDI; N. LAUFER; P. CAHN; J. COX; H. SALOMON
Mapping and cross-clade evaluation of Nef-specific cellular immune responses in HIV-1+ individuals reveal breadth underestimation and discrepant patterns of T cell functionality.
4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. 19th ASHM Conference. Sydney,
Lugar: Australia. July 22-25,; Año: 2007;
M. VIGNOLES; G. BARBONI; M.R. AGOSTI; J. QUARLERI; M. GARCÍA; V. GIRAUDI; S. GONZÁLEZ AYALA; H. SALOMÓN
Rapid emergence of primary mutations associated with antiretroviral drug resistance in HIV-infected children under HAART
4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. 19th ASHM Conference. Sydney,
Lugar: Australia. July 22-25,; Año: 2007;
G TURK, MM GHERARDI, N LAUFER, P CAHN, J COX, H SALOMON
Cross-clade evaluation of nef-specific CTLs in HIV+ individuals reveals breadth underestimation and discrepant patterns of T cell functionality
AIDS Vaccine 2007
Lugar: Seattle, Washington, USA; Año: 2007;
DI CORRADO P; VIGNOLES M; SALOMÓN H
Análisis de una intervención para mejorar el cumplimiento del diagnóstico perinatal de HIV
Congreso Nacional de SIDA
Lugar: Paraná, Entre Rios; Año: 2007;
DILERNIA D; LOURTAU L; PARLANTE A; LOSSO M; SALOMÓN H
Selección poblacional de variantes de escape del HIV-1 a la respuesta CTL en la ciudad de Buenos Aires
Congreso Nacional de SIDA,
Lugar: Paraná, Entre Rios; Año: 2007;
VIGNOLES M; BARBONI G; AGOSTI M; QUARLERI J; GONZÁLEZ AYALA S; SALOMÓN H
Baja supresión viral en niños infectados con HIV bajo HAART: análisis de las posibles causas.
Congreso Nacional de SIDA
Lugar: Paraná, Entre Rios; Año: 2007;
DARÍO ALBERTO DILERNIA; L LOURTAU; L JONES; G TURK; M GOMEZ-CARRILLO; C BAUTISTA; H SALOMÓN
Accumulation of CTL escape variants and HLA-driven convergence of viral subtypes.
CROI 2007 ? 15th Conference on Retroviruses and Opportunistic Infections.
Lugar: Boston MA, USA; Año: 2007;
TURK G,; GHERARDI M; LAUFER N; SARACCO M; COX J; CAHN P; SALOMÓN H
Magnitud, amplitud y perfil funcional de la respuesta inmune celular específica en pacientes recientemente infectados con variantes intersubtipo BF del HIV
Congreso Nacional de SIDA,
Lugar: Paraná, Entre Rios; Año: 2007;
GOMEZ A; DILERNIA D; LOURTAU L; LOSSO M; SALOMON H; GOMEZ CARRILLO M
Surveillance of HIV-1 subtypes in Buenos Aires, Argentina.
XVI International AIDS Conference – Time to Deliver.
Lugar: Toronto, Canadá; Año: 2006;
DURAN A; LOSSO M; SALOMON H; PAMPURO S; HARRIS R; SOTO-RAMIREZ L; READ J; NISDI PERINATAL STUDY GROUP
Development of antiretroviral resistance among HIV-1-infected women first exposed to antiretrovirals during pregnancy: the NICHD international site development initiative (NISDI) perinatal study.
XVI International AIDS Conference – Time to Deliver.
Lugar: Toronto, Canadá; Año: 2006;
RUBIO AE; ABRAHA A; TROYER RM; TURK G; ARTS EJ; SALOMON H
Determination of ex-vivo fitness of different HIV-1 subtypes and intersubtype BF recombinants circulating in Argentina.
XVI International AIDS Conference – Time to Deliver.
Lugar: Toronto, Canadá; Año: 2006;
REYNOSO R; MINCES L; CASSINO L; SALOMÓN H; QUARLERI J
HIV-1 infection downregulates cellular telomerase activity at nuclear compartment of lymphoblastoid T cells.
XVI International AIDS Conference – Time to Deliver.
Lugar: Toronto, Canadá; Año: 2006;
ZALA C; HOGG R; SALOMON H; CHAN K; CERIOTTO M; BELTRAN M; BURGOS M; MONTANER JS; CAHN P
Outcomes of HAART in HIV-1 infected individuals in Buenos Aires, Argentina.
XVI International AIDS Conference – Time to Deliver.
Lugar: Toronto, Canadá; Año: 2006;
G TURK; M CAROBENE; A RUBIO; A MONCZOR; M GÓMEZ-CARRILLO; H SALOMÓN
Higher transactivation activity associated with LTR and Tat elements from BF intersubtype recombinant variants.
13th Conference on Retroviruses and Opportunistic Infections.
Lugar: Colorado Convention Center, Denver. Colorado. Estados Unidos.; Año: 2006;
H PEREZ; M VIGNOLES; N LAUFER; N SCHVACHSA; G DOLCINI; P COLL; J LATTNER; M ROLON; H SALOMON; P CAHN
Post-partum interruption of a triple drug regimen containing nevirapine for prevention of mother-to-child HIV transmission does not select the K103N mutation.
13th Conference on Retroviruses and Opportunistic Infections.
Lugar: Denver, Colorado, Estados Unidos; Año: 2006;
M VIGNOLES; S GONZÁLEZ-AYALA; G BARBONI; MR AGOSTI; V GIRAUDI; H SALOMÓN
High frequency of mutations associated to antiretroviral drug resistance in recently diagnosed HIV-infected children.
13th Conference on Retroviruses and Opportunistic Infections.
Lugar: Denver, Colorado, Estados Unidos; Año: 2006;
AM RODRIGUEZ; D MÓNACO; H SALOMÓN; M ESTEBAN; MM GHERARDI
Intranasal delivery of DNA IL-12 during mucosal DNA-prime/MVA-boost immunization schemes enhanced the cellular immune response against HIV-1 Env antigen.
AIDS VACCINE 06 – Fifth International Conference.
Lugar: Amsterdam, The Netherlands; Año: 2006;
G TURK; MM GHERARDI; N LAUFER; P CAHN; J COX; H SALOMON
Epidemiological studies revealed that in Argentina, early predominance of B subtype has been overshadowed by the emergence of BF recombinants. Until correlates of protection are well understood, existence and determiants of cross-clade immune responses sh
AIDS VACCINE 06 – Fifth International Conference
Lugar: Amsterdam, The Netherlands; Año: 2006;
MARONE RO; PANDO MA; AVILA M; SALOMON H; SQUIQUERA L
Gay men with casual partners, sexual role and HIV infection
XVI International AIDS Conference – Time to Deliver
Lugar: Toronto, Canadá; Año: 2006;
MARTINEZ PERALTA LA; AGOSTI MR; RIMOLDI I,; ARRESEIGOR S; VIGNOLES M; SALOMON HE; GONZALEZ AYALA SE
Mother to child transmission: report of an Argentine Pediatric Hospital from 1987 to 2005.
XVI International AIDS Conference – Time to Deliver.
Lugar: Toronto, Canadá; Año: 2006;
SCHVACHSA NS; DILERNIA D; PIPPO M; BURGARD M; SALOMON H; ROUZIOUX C
Applicability of the real time PCR assay in measuring viral load in HIV-1 BF recombinant variants infected individuals
3rd IAS Conference on HIV Pathogenesis and Treatment
Lugar: Rio de Janeiro, Brasil; Año: 2005;
REYNOSO RP; VIGNOLES M; TURK GJ; MINCES LR; SARACCO M; SALOMON H; QUARLERI JF
Telomerase activity remains unchanged alter HIV-1 Tat expression in GHOST-cells: comparative analysis between HIV-1 subtype B and BF isolates
3rd IAS Conference on HIV Pathogenesis and Treatment.
Lugar: Rio de Janeiro, Brasil; Año: 2005;
MINCES LR; REYNOSO RP; BOLCIC FM; SALOMON H; QUARLERI JF
Telomerase activity and telomeric length remain unchanged in JurkaT-cells infected with HIV-1
3rd IAS Conference on HIV Pathogenesis and Treatment.
Lugar: Rio de Janeiro, Brasil; Año: 2005;
DILERNIA D; LOSSO MH; LOURTAU L; PARLANTE A; SALOMON H; GÓMEZ CARRILLO M
Evidence of “non B-non BF” HIV-1 subtypes in newly diagnosed patients from Buenos Aires, Argentina
3rd IAS Conference on HIV Pathogenesis and Treatment.
Lugar: Rio de Janeiro, Brasil; Año: 2005;
DILERNIA DA; LOURTAU L; MARONE R; CAROBENE M; PAMPURO S; EBENSRTEJIN J; LOSSO M; SALOMON H.
Prevalence of drug-resistance associated mutations among newly diagnosed HIV-1 infected individuals at two voluntary testing centres in the city of Buenos Aires, Argentina
3rd IAS Conference on HIV Pathogenesis and Treatment
Lugar: Rio de Janeiro, Brasil; Año: 2005;
ZALA C; HOGG R; SALOMON H; CHAN K; HAMILTON G; MONTANER J; CAHN P
Outcomes of HAART in HIV-1 infected individuals in Buenos Aires, Argentina
3rd IAS Conference on HIV Pathogenesis and Treatment
Lugar: Rio de Janeiro, Brasil; Año: 2005;
DARÍO ALBERTO DILERNIA; LEONARDO LOURTAU; RUBÉN MARONEANA MONCZOR; MARCELO LOSSO; HORACIO SALOMÓN
Seroprevalence and Viral Characterization in Two Voluntary TesTing Centres, Buenos Aires City, Argentina
AIDS Vaccine 2005: Together, a better future for all.
Lugar: Montreal, Québec, Canadá; Año: 2005;